Veru Announces FDA Grant of Fast Track Designation for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

Stock Information for Veru Inc.

Loading

Please wait while we load your information from QuoteMedia.